- Home
- SVII vs BLDE Comparison
SVII vs BLDE Comparison
Compare SVII & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- BLDE
- Stock Information
- Founded
- SVII 2021
- BLDE 2014
- Country
- SVII United States
- BLDE United States
- Employees
- SVII N/A
- BLDE N/A
- Industry
- SVII Blank Checks
- BLDE Aerospace
- Sector
- SVII Finance
- BLDE Consumer Discretionary
- Exchange
- SVII Nasdaq
- BLDE Nasdaq
- Market Cap
- SVII 111.1M
- BLDE 276.7M
- IPO Year
- SVII 2022
- BLDE N/A
- Fundamental
- Price
- SVII $11.22
- BLDE $3.95
- Analyst Decision
- SVII
- BLDE Buy
- Analyst Count
- SVII 0
- BLDE 1
- Target Price
- SVII N/A
- BLDE $6.00
- AVG Volume (30 Days)
- SVII 74.3K
- BLDE 1.6M
- Earning Date
- SVII 01-01-0001
- BLDE 11-12-2024
- Dividend Yield
- SVII N/A
- BLDE N/A
- EPS Growth
- SVII 13.16
- BLDE N/A
- EPS
- SVII 0.36
- BLDE N/A
- Revenue
- SVII N/A
- BLDE $241,814,000.00
- Revenue This Year
- SVII N/A
- BLDE $11.34
- Revenue Next Year
- SVII N/A
- BLDE $5.73
- P/E Ratio
- SVII $31.11
- BLDE N/A
- Revenue Growth
- SVII N/A
- BLDE 12.04
- 52 Week Low
- SVII $10.81
- BLDE $2.45
- 52 Week High
- SVII $11.70
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- SVII 39.53
- BLDE 47.19
- Support Level
- SVII $11.20
- BLDE $3.95
- Resistance Level
- SVII $11.24
- BLDE $4.45
- Average True Range (ATR)
- SVII 0.01
- BLDE 0.37
- MACD
- SVII 0.01
- BLDE -0.08
- Stochastic Oscillator
- SVII 40.00
- BLDE 11.45
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.